These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 9570553

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Immunology in the medical practice. XXVII. Mannose-binding lectin, an important link for nonspecific or hereditary immune reaction].
    van Deuren M.
    Ned Tijdschr Geneeskd; 2000 Jun 17; 144(25):1214-9. PubMed ID: 10897301
    [Abstract] [Full Text] [Related]

  • 23. Mannose-binding lectin (MBL) in health and disease.
    Turner MW.
    Immunobiology; 1998 Aug 17; 199(2):327-39. PubMed ID: 9777416
    [Abstract] [Full Text] [Related]

  • 24. L-Ficolin/mannose-binding lectin-associated serine protease complexes bind to group B streptococci primarily through N-acetylneuraminic acid of capsular polysaccharide and activate the complement pathway.
    Aoyagi Y, Adderson EE, Rubens CE, Bohnsack JF, Min JG, Matsushita M, Fujita T, Okuwaki Y, Takahashi S.
    Infect Immun; 2008 Jan 17; 76(1):179-88. PubMed ID: 17938215
    [Abstract] [Full Text] [Related]

  • 25. Leishmania (Viannia) braziliensis: interaction of mannose-binding lectin with surface glycoconjugates and complement activation. An antibody-independent defence mechanism.
    Ambrosio AR, De Messias-Reason IJ.
    Parasite Immunol; 2005 Sep 17; 27(9):333-40. PubMed ID: 16149991
    [Abstract] [Full Text] [Related]

  • 26. Mannose binding lectin enhances IL-1beta and IL-10 induction by non-lipopolysaccharide (LPS) components of Neisseria meningitidis.
    Sprong T, Jack DL, Klein NJ, Turner MW, van der Ley P, Steeghs L, Jacobs L, van der Meer JW, van Deuren M.
    Cytokine; 2004 Oct 21; 28(2):59-66. PubMed ID: 15381182
    [Abstract] [Full Text] [Related]

  • 27. Molecular interactions between MASP-2, C4, and C2 and their activation fragments leading to complement activation via the lectin pathway.
    Wallis R, Dodds AW, Mitchell DA, Sim RB, Reid KB, Schwaeble WJ.
    J Biol Chem; 2007 Mar 16; 282(11):7844-51. PubMed ID: 17204478
    [Abstract] [Full Text] [Related]

  • 28. Human IgA activates the complement system via the mannan-binding lectin pathway.
    Roos A, Bouwman LH, van Gijlswijk-Janssen DJ, Faber-Krol MC, Stahl GL, Daha MR.
    J Immunol; 2001 Sep 01; 167(5):2861-8. PubMed ID: 11509633
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. C-type lectins and galectins mediate innate and adaptive immune functions: their roles in the complement activation pathway.
    Vasta GR, Quesenberry M, Ahmed H, O'Leary N.
    Dev Comp Immunol; 1999 Sep 01; 23(4-5):401-20. PubMed ID: 10426431
    [Abstract] [Full Text] [Related]

  • 31. The (alpha2-->8)-linked polysialic acid capsule and lipooligosaccharide structure both contribute to the ability of serogroup B Neisseria meningitidis to resist the bactericidal activity of normal human serum.
    Kahler CM, Martin LE, Shih GC, Rahman MM, Carlson RW, Stephens DS.
    Infect Immun; 1998 Dec 01; 66(12):5939-47. PubMed ID: 9826376
    [Abstract] [Full Text] [Related]

  • 32. The effect of mannan-binding lectin on opsonophagocytosis of Neisseria meningitidis.
    Drogari-Apiranthitou M, Fijen CA, Thiel S, Platonov A, Jensen L, Dankert J, Kuijper EJ.
    Immunopharmacology; 1997 Dec 01; 38(1-2):93-9. PubMed ID: 9476120
    [Abstract] [Full Text] [Related]

  • 33. Complement factor C3 deposition and serum resistance in isogenic capsule and lipooligosaccharide sialic acid mutants of serogroup B Neisseria meningitidis.
    Vogel U, Weinberger A, Frank R, Müller A, Köhl J, Atkinson JP, Frosch M.
    Infect Immun; 1997 Oct 01; 65(10):4022-9. PubMed ID: 9317002
    [Abstract] [Full Text] [Related]

  • 34. The lipopolysaccharide structures of Salmonella enterica serovar Typhimurium and Neisseria gonorrhoeae determine the attachment of human mannose-binding lectin to intact organisms.
    Devyatyarova-Johnson M, Rees IH, Robertson BD, Turner MW, Klein NJ, Jack DL.
    Infect Immun; 2000 Jul 01; 68(7):3894-9. PubMed ID: 10858200
    [Abstract] [Full Text] [Related]

  • 35. Regulation of in situ complement activation via the lectin pathway in patients with IgA nephropathy.
    Endo M, Ohi H, Satomura A, Hidaka M, Ohsawa I, Fujita T, Kanmatsuse K, Matsushita M, Fujita T.
    Clin Nephrol; 2001 Mar 01; 55(3):185-91. PubMed ID: 11316237
    [Abstract] [Full Text] [Related]

  • 36. Improvements on the purification of mannan-binding lectin and demonstration of its Ca(2+)-independent association with a C1s-like serine protease.
    Tan SM, Chung MC, Kon OL, Thiel S, Lee SH, Lu J.
    Biochem J; 1996 Oct 15; 319 ( Pt 2)(Pt 2):329-32. PubMed ID: 8912663
    [Abstract] [Full Text] [Related]

  • 37. An assay for the mannan-binding lectin pathway of complement activation.
    Petersen SV, Thiel S, Jensen L, Steffensen R, Jensenius JC.
    J Immunol Methods; 2001 Nov 01; 257(1-2):107-16. PubMed ID: 11687244
    [Abstract] [Full Text] [Related]

  • 38. Mannose-binding lectin is a component of innate mucosal defense against Cryptosporidium parvum in AIDS.
    Kelly P, Jack DL, Naeem A, Mandanda B, Pollok RC, Klein NJ, Turner MW, Farthing MJ.
    Gastroenterology; 2000 Nov 01; 119(5):1236-42. PubMed ID: 11054381
    [Abstract] [Full Text] [Related]

  • 39. Control of the classical and the MBL pathway of complement activation.
    Petersen SV, Thiel S, Jensen L, Vorup-Jensen T, Koch C, Jensenius JC.
    Mol Immunol; 2000 Oct 01; 37(14):803-11. PubMed ID: 11257302
    [Abstract] [Full Text] [Related]

  • 40. Calcium-independent haemolysis via the lectin pathway of complement activation in the guinea-pig and other species*.
    Zhang Y, Suankratay C, Zhang X, Jones DR, Lint TF, Gewurz H.
    Immunology; 1999 Aug 01; 97(4):686-92. PubMed ID: 10457224
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.